A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
Popular cities in New Jersey
New Jersey is a vital center for a diverse array of clinical trials, largely in part due to its robust healthcare network and prominent medical research institutions. Key organizations such as Rutgers Cancer Institute, Hackensack Meridian Health, and Cooper University Health Care are leading the way in groundbreaking studies in the state. These institutions are recognized for their innovative research in areas like cancer, cardiovascular health, and neurology, making New Jersey a critical player in advancing medical science and patient care.
Why choose New Jersey for clinical trials?
New Jersey offers a vast array of advantages for individuals considering participation in clinical trials. The state has a diverse population, which enriches the participant pool and improves the reliability and applicability of research findings. Additionally, New Jersey is home to some of the nation’s leading medical research institutions, known for their innovative approaches and focus on advancing healthcare.
By choosing to participate in a clinical trial in New Jersey, participants not only gain access to cutting-edge treatments but also play a vital role in advancing important medical research. The state’s well-established clinical research infrastructure ensures participants receive exceptional care and support throughout their journey, contributing to meaningful advancements in healthcare.
Common conditions studied in New Jersey
New Jersey is a prominent center for clinical research, with several key areas of focus reflecting the state's strengths and the expertise of its leading medical institutions.
Mental health
The state places a strong emphasis on mental health research, addressing conditions such as depression, anxiety disorders, and schizophrenia. Clinical trials focus on evaluating new pharmacological treatments, exploring psychotherapeutic interventions, and testing holistic approaches to mental health care.
By improving treatment strategies and understanding the underlying mechanisms of mental health disorders, these studies aim to enhance overall patient well-being and reduce stigma associated with mental illness.
Cardiovascular diseases
With institutions such as Cooper University Health Care and the University of Medicine and Dentistry of New Jersey, the state is a leader in cardiovascular research. Clinical trials here focus on a number of heart-related conditions, including coronary artery disease, heart failure, and arrhythmias.
Researchers explore new medications, innovative surgical techniques, and comprehensive rehabilitation strategies designed to improve cardiac health. These trials are essential for developing effective prevention methods and enhancing recovery outcomes for patients.
Neurological disorders
Research on neurological conditions is robust in New Jersey, with a focus on diseases like Alzheimer’s, Parkinson’s, and multiple sclerosis (MS). Institutions such as the Kessler Institute for Rehabilitation and Rutgers University are conducting trials that investigate innovative treatment modalities, including new pharmacological agents, cognitive therapies, and rehabilitation strategies.
Cancer
New Jersey is home to renowned cancer research institutions like the Rutgers Cancer Institute and Hackensack Meridian Health. These centers are at the forefront of studies on various cancers, including breast, prostate, lung, and colorectal cancer.
Researchers in New Jersey are pioneering advancements in immunotherapy and targeted treatments, which tailor therapies to individual patient profiles based on genetic information. These clinical trials not only aim to improve survival rates but also to enhance the quality of life for patients by minimizing side effects and optimizing treatment protocols.
Interested in learning more about how clinical trials for cancer work? Explore our guide to better understand oncology clinical trials and how they contribute to advancing cancer treatments.
Rare diseases
New Jersey's research institutions are also engaged in studying various rare diseases, such as cystic fibrosis and specific genetic disorders. Clinical trials in this area aim to develop novel therapies and improve understanding of these conditions, which often lack adequate treatment options. Researchers work on gene therapies, enzyme replacements, and other innovative approaches to provide new hope for patients with rare and often severe health issues.
Diabetes and metabolic disorders
New Jersey actively engages in research related to diabetes, particularly Type 1 and Type 2 diabetes. Clinical trials often explore new insulin formulations, advanced monitoring technologies like continuous glucose monitors, and lifestyle interventions designed to help patients manage their conditions more effectively.
The goal is to enhance patient outcomes and reduce complications associated with diabetes, addressing a significant public health challenge in the state.
Local regulations and guidelines
In New Jersey, clinical trials are governed by a combination of federal and state regulations designed to protect participant safety and ensure ethical research practices. Key federal guidelines include compliance with FDA regulations, which require Investigational New Drug (IND) or Investigational Device (IDE) approvals and adherence to Good Clinical Practice (GCP) standards. All trials must also receive approval from an Institutional Review Board (IRB), which assesses study protocols to ensure informed consent and minimize risks.
In the state, the New Jersey Department of Health oversees clinical research activities, emphasizing the importance of informed consent and additional protections for vulnerable populations, such as children and individuals with cognitive impairments. Researchers must comply with HIPAA regulations to safeguard participants' health information. Individual institutions may have their own ethics committees and policies that further enhance oversight.
Benefits of participating in clinical trials
Participating in a clinical trial offers individuals a remarkable chance to explore innovative treatments and therapies that are not yet available to the general public. This is particularly beneficial for those whose conditions have not responded to conventional therapies. Participants receive specialized care from dedicated healthcare professionals who closely monitor their health, ensuring both safety and the assessment of the new treatments' effectiveness.
Furthermore, participation in clinical trials plays a crucial role in advancing medical science. By taking part, individuals gain access to potentially transformative therapies while also contributing to the broader evolution of healthcare practices. Their involvement can lead to groundbreaking discoveries that enhance our understanding of various diseases and expand treatment options, ultimately providing renewed hope for many patients facing difficult health challenges.
How to enroll in a clinical trial in New Jersey
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify your trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select your preferred location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore study details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the health profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.